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Abstract
Background: Skull base osteomyelitis is an uncommon disease that usually complicates a malignant external otitis
with temporal bone involvement. It affects predominantly diabetic and immunocompromised males and has a high
mortality rate. Pseudomonas aeruginosa is the most common causative organism. Currently, there is no consensus
about the best therapeutic option. Here we describe a case of severe skull base osteomyelitis caused by Pseudomonas
aeruginosa with progressive palsy of cranial nerves that was successfully managed with prolonged outpatient
continuous infusion of ceftazidime plus oral ciprofloxacin.
Case presentation: A 69-year-old Caucasian man presented with dysphagia, headache, and weight loss. He
complained of left earache and purulent otorrhea. Over the following weeks he developed progressive palsy
of IX, X, VI, and XII cranial nerves and papilledema. A petrous bone computed tomography scan showed a
mass in the left jugular foramen with a strong lytic component that expanded to the cavum. A biopsy was
then performed and microbiological cultures grew Pseudomonas aeruginosa. After 6 weeks of parenteral antibiotic
treatment, our patient was discharged and treatment was continued with a domiciliary continuous infusion of a beta-
lactam through a peripherally inserted central catheter, along with an oral fluoroquinolone for 10 months. Both
radiological and clinical responses were excellent.
Conclusions: Skull base osteomyelitis is a life-threating condition; clinical suspicion and correct microbiological
identification are key to achieve an accurate and timely diagnosis. Due to the poor outcome of Pseudomonas
aeruginosa skull base osteomyelitis, prolonged outpatient parenteral antibiotic therapy administered by continuous
infusion could be a valuable option for these patients.
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Background
Skull base osteomyelitis (SBO) is a rare disease with a
high mortality rate, up to 10–20% [1]. It was first
described in 1959 by Meltzer and Keleman [2]. It affects
predominantly diabetic or immunocompromised men in
their sixties. Typical cases arise as a complication of ma-
lignant external otitis with temporal bone involvement.
Pseudomonas aeruginosa is the causative organism in
75–95 % of cases [3]. However, there are also atypical
cases of central SBO that usually affect sphenoid and/or
occipital bones and that are not associated with
malignant external otitis. Main clinical features are
otalgia, facial pain, and headache (90%). Facial nerve
palsy complicates around 60% of cases [4]. Venous sinus
thrombosis, meningitis, cerebritis or abscess formation
are less frequent complications [5]. Early treatment is
key to success. Empiric treatment should be based on
anti-Pseudomonal agents [6]. Optimal treatment is not
clear; usually a course of intravenous treatment is
followed by a course of oral antibiotics with a highly
variable duration [7]. Here we describe a case of a pa-
tient with SBO caused by Pseudomonas aeruginosa with
extensive soft tissue and bone involvement complicated
with progressive palsy of cranial nerves, which was ini-
tially misdiagnosed as malignancy and was managed
with prolonged domiciliary parenteral therapy.
Case presentation
A 69-year-old Caucasian man was admitted to hospital
with a 2-week history of dysphagia to both liquids and
solids, headache, and weight loss. His medical history
was remarkable for hypertension and type 2 diabetes
mellitus treated with oral antidiabetics. Three months
prior to the hospital admission, he complained of otalgia
and left ear discharge; therefore, a diagnosis of otitis
externa was made and he was given ear drops containing
antibiotics.
On physical examination his vital signs were normal
and he had no fever. A neurological examination revealed
absence of nausea reflex. There was no evidence of other
cranial nerve palsies and a peripheral neurological exam-
ination was normal. Purulent otorrhea and a bulging left
tympanic membrane were seen through the otoscope. The
examination was otherwise unremarkable. Initial blood
test results showed mild hyponatremia (132 mEq/L) and
an elevated C-reactive protein (CRP) (88 mg/L) and
erythrocyte sedimentation rate (ESR) (104 mm/h). A pet-
rous bone computed tomography (CT) scan and a cranial
magnetic resonance imaging (MRI) scan showed a vascu-
larized mass in the left jugular foramen, extending to the
middle ear and breaking its front wall (Fig. 1). The find-
ings were suggestive of a jugulo-tympanic glomus, but it
was finally ruled out because of a normal arteriography.
An esophagogastroduodenoscopy was also normal. Since
the main suspicion was a primary or metastatic cancer, a
tympanostomy was performed and a middle ear biopsy re-
sult was negative for malignancy.
Two weeks later, our patient was referred for transient
visual obscurations, double vision, worsening headache,
and vomiting. On neurological examination, binocular
diplopia and left hypoglossal nerve palsy were observed,
together with ptosis of the left soft palate and paralysis
of left arytenoid, suggesting VI, IX, and X cranial nerve
palsies. Funduscopy revealed papilledema. A new cranial
CT scan showed progression of the left jugular foramen
lytic lesion now expanding to the cavum (Fig. 2). A
positron emission tomography (PET) scan showed a
mass with a standardized uptake value (SUV) of 7.4
(Fig. 3). Intracranial hypertension was suspected, and
therefore a diagnostic and therapeutic lumbar puncture
performed. Cerebrospinal fluid (CSF) showed 60 leuko-
cytes/μL (81% mononuclear cells), glucose 66 mg/dL,
and proteins 189 mg/dL. CSF cultures and nucleic acid
testing results were negative, as was CSF cytology. An
endoscopic biopsy of the cavum mass was then performed
obtaining purulent material. The anatomopathological study
showed acute and chronic inflammation and was negative
for malignancy; microbiological cultures grew Pseudomonas
aeruginosa. A final diagnosis of SBO with multiple cranial
nerve palsies, intracranial hypertension, aseptic meningitis,
and a secondary syndrome of inappropriate antidiuretic hor-
mone secretion (SIADH) was made. Intravenous merope-
nem (minimal inhibitory concentration [MIC]: ≤1 μg/mL)
and ciprofloxacin (MIC: ≤0.5 μg/mL) were initiated. Neuro-
surgeons did not recommend surgical debridement. After 6
Fig. 1 Petrous bone computed tomography scan shows occupation
of the left middle ear and mastoid cells and erosion of the anterior
wall of the middle ear (star)
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weeks, our patient was discharged with oral ciprofloxacin
(750 mg twice daily) along with intravenous ceftazidime (4 g
daily; MIC: ≤ 1 μg/mL) given domiciliary as continuous in-
fusion through a peripherally inserted central catheter
(PICC). Clinical progress was slow but favorable, with
normalization of the acute-phase reactants and no metabolic
activity on the PET scan, so antibiotics were stopped after
11 months of parenteral treatment. Despite the prolonged
antibiotic therapy, no remarkable side effects were observed.
One month after stopping antibiotics, a new PET scan did
not show any metabolic activity, and levels of CRP and ESR
remained low. All neurological deficits resolved, except for a
mild persistent left sixth cranial nerve palsy.
Discussion
We describe the case of a patient with SBO with
multiple and progressive cranial nerve palsies initially
misdiagnosed as a malignant lesion. Information about
this entity is circumscribed to case reports and small
case series [3, 4, 6, 8–11], a systematic review compris-
ing 42 central SBO cases [1], and a meta-analysis of 83
SBO cases [4]. Large tertiary hospitals report around
three cases a year [3, 4, 11].
There is some confusion on the terminology and some
authors refer to SBO as the entity resulting from compli-
cation of a malignant external otitis [6, 8, 9, 12], while
others include also the so-called atypical or central SBO.
The latter usually affects sphenoid and/or occipital bones
and it may be secondary to an otogenic, sinusal, odonto-
genic or hematogenous infection, although there are also
cases with no obvious infective source [3, 4, 7, 10]. Some
authors prefer to avoid the term SBO and define instead a
lateral temporal bone and a medial temporal bone
osteomyelitis [11]. In our case, the SBO was preceded by a
malignant external otitis so the infection most probably
traversed the fissures of Santorini and the tympanomas-
toid suture to the compact bone, finally affecting the skull
base. In a recent meta-analysis, 59% of patients had some
cranial nerve palsy (that persisted after therapy in 41%)
while disease-specific mortality reached 22% [4]. The VII
cranial nerve is the cranial nerve most commonly affected.
Contrary to this, in our patient the VII cranial nerve was
not involved and the infection expanded directly infero-
medially to the jugular foramen, giving rise to Vernet’s
syndrome (glossopharyngeal nerve, vagus nerve and,
accessory nerve). As the infection progressed, further in-
volvement of the hypoglossal nerve at its exit at the hypo-
glossal canal (Collet-Sicard syndrome) was noticed.
Involvement of the VI cranial nerve probably occurred at
the Dorello’s canal where it passes over the edge of the
petrous pyramid.
Pseudomonas aeruginosa is the principal causative
microorganism of SBO, although other bacteria like
Staphylococcus aureus, Klebsiella spp., Proteus spp., and
Fig. 2 Cranial computed tomography scan shows a mass of soft
tissue (arrow) surrounding the internal jugular vein and the carotid
artery at the left jugular foramen with signs of bone erosion and
destruction. The lesion extends medially and causes bone destruction of
the left occipital condyle and the left side edge of the clivus and erosion
of the posterior edge of the oval hole. In the petrous bone it extends to
the middle ear and causes erosion of the anterior wall of the tympanic
cavity. The mass goes along the petrous carotid reducing its caliber and
causing bone destruction of the anterior edge of the carotid canal
extending to the petrous apex
Fig. 3 Positron emission tomography scan showing an uptake with
a standardized uptake value of 7.4 at the mass location
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Mycobacterium chelonae have been reported [1, 4]. Fun-
gal infection also needs to be considered, especially in
patients with underlying chronic sinusitis, sinusal pain,
facial/periorbital swelling or in the absence of ear dis-
charge [3]. Candida, Aspergillus, Rhizopus, and Mucor
have been involved [4]. In the review by Blyth et al.,
Zygomycetes were responsible for more than 50% of
fungal SBO, and as a result amphotericin B is suggested
as the preferred empirical treatment when fungal SBO is
suspected [3].
CRP and ESR are often used as a diagnostic adjunct in
SBO and especially for the follow-up of patients.
Imaging examinations such as CT and MRI are crucial
to characterize the lesion and to evaluate the degree of
bone and soft tissue involvement. The differential diag-
nosis of soft tissue masses at the skull base is wide and
comprise malignant lesions (nasopharyngeal carcinoma,
squamous cell carcinoma of the external auditory canal,
schwannoma, metastases, and multiple myeloma), infec-
tious and inflammatory diseases (SBO, inflammatory
pseudotumor, granulomatosis with polyangeitis, tubercu-
losis, and sarcoidosis) and others, such as cholesteatoma,
dural arteriovenous fistula, fibrous dysplasia, and Paget
disease [1, 5, 10, 13]. The use of imaging tests that
measure the activity of infection also has a role in the
diagnosis and follow-up of these patients. The use of
single-photon emission tomography-computed tomog-
raphy (SPECT-CT) with 67Ga or 111In-labeled leukocytes
has shown higher specificity than scintigraphy, CT scan
or SPECT alone [14]. In a recent study by Sharma et al.,
SPECT-CT was the most sensitive technique for SBO
diagnosis (sensitivity = 100%, specificity = 50%), while
CT was the most specific (sensitivity = 73%, specificity =
100%) [15]. In a study by Filippi et al., specificity of
SPECT-CT was higher than SPECT alone (89% vs. 78%)
[16]. SPECT scan has also shown good predictive value
for long-term outcomes [9]. Obtaining tissue specimens
is paramount to determine the microbial etiology and
needs proper microbiological and histopathological pro-
cessing of samples. In our case, improper management
of initial middle ear samples (that were not sent to the
microbiology laboratory) may have contributed to the
diagnostic delay.
Empiric treatment of SBO should include broad-
spectrum antibiotics with good anti-Pseudomonas activ-
ity, evaluating the need of added antifungal therapy [6].
Treatment duration and route of administration are not
well-resolved issues and a wide variety of therapeutic ap-
proaches have been adopted in previously reported
cases. Initial intravenous treatment is usually followed
by long-term oral therapy, providing an adequate clinical
response is achieved with intravenous antibiotics and ac-
tive oral agents exist. However, Pseudomonas aeruginosa
osteomyelitis has been associated with lower cure rates
and higher recurrence risk [17], therefore antimicrobial
therapy has been continued domiciliary for several weeks
to minimize relapses [7, 18]. In the meta-analysis by
Ridder et al., median length of inpatient treatment was 32
days (range: 7–83), while median length of subsequent
oral treatment was 1.5 months (range 0–16 months) [4].
Antibiotic regimens comprising an initial 4–6 weeks
course of intravenous treatment followed by 6 to 12
months of oral medication, guided by clinical response,
have been recommended [7]. Continuous infusion of anti-
biotics allows outpatient administration of parenteral ther-
apy, thereby reducing health care resources consumption
[19]. Administration of beta-lactams by continuous intra-
venous infusion generates higher blood and tissue concen-
trations and allows longer time above the MIC compared
with intermittent dosing, which is particularly useful for
bacteria with high MIC values, such as Pseudomonas
aeruginosa [20]. Because of the wide soft tissue and bone
involvement, the critical location of the abscesses, the lack
of adjunct surgical debridement, the Pseudomonal
etiology, and the absence of side effects, we decided to
give the patient a prolonged course of intravenous ceftazi-
dime with domiciliary continuous infusion through a
PICC, along with oral ciprofloxacin. Our strategy was suc-
cessful, allowing for prolonged outpatient intravenous
treatment. Remarkably, no side effects were noticed after
11 months of beta-lactam and fluoroquinolone treatment.
We believe this is a valid approach, which may be crucial
in cases of drug-resistant microorganisms with limited
therapeutic options.
The role of hyperbaric oxygen is not well defined, but
may provide some benefit reversing the hypoxia, im-
proving the phagocytic activity against aerobic microor-
ganisms, and stimulating angiogenesis; a positive effect
on the cranial nerve palsies recovery has been reported
[4, 21, 22]. Surgery may be needed for decompressing
cranial nerves in selected cases [11]. The role of surgical
debridement remains controversial. It has no clear im-
pact on survival, antimicrobial treatment duration nor
prognosis [9, 18, 21], except in the case of fungal SBO
[3]. Nevertheless, surgical debridement could remove
devitalized tissue and reduce infection load in order to
improve penetration of antibiotics and some authors
advocate for an early and forceful surgical approach,
especially in patients with protracted ear infections and
signs of cranial nerve involvement [4].
Close radiological and clinical follow-up of SBO is
mandatory. Follow-up gallium scans have been proposed
at 1 week and 12 weeks after antibiotics cessation to
search for recurrence [22].
Conclusions
SBO can be misdiagnosed as malignancy, especially
when there is a strong lytic bone destruction and
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important soft tissue involvement, as in the reported
case. Clinical suspicion, even in the absence of an obvi-
ous infective source, and microbiological processing of
samples are key to achieve a correct and timely diagno-
sis. Pseudomonas aeruginosa is the most frequent causa-
tive organism. Outpatient parenteral antibiotic therapy
administered by continuous infusion could be a suitable
option to prolong intravenous treatment in this severe
disease, especially when difficult-to-treat organisms like
Pseudomonas aeruginosa are implicated.
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